| Joan Mk Fox, MD | |
|
920 E 28th St # St5, Suite 700, Minneapolis, MN 55407-1139 | |
| (612) 863-9062 | |
| (612) 863-9252 |
| Full Name | Joan Mk Fox |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 920 E 28th St # St5, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679593925 | NPI | - | NPPES |
| 290013500 | Other | MN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 31079 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Lung Center Ltd | 2860391521 | 12 |
| Northstar Sleep Center Llc | 7315104064 | 5 |
News Archive
One of the doctors who will NOT be standing behind the President today is one of his most vocal opponents. But he would have been there if the White House had its way.
The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
EntreMed, Inc., today announced the presentation of data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor. Data from the Phase 1 studies with ENMD-2076 in patients with multiple myeloma and relapsed or refractory leukemia were presented by EntreMed investigators during poster sessions at the 2010 American Society of Hematology Annual Meeting being held December 4-7 in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Minnesota Lung Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655813 PECOS PAC ID: 2860391521 Enrollment ID: O20040102000187 |
News Archive
One of the doctors who will NOT be standing behind the President today is one of his most vocal opponents. But he would have been there if the White House had its way.
The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
EntreMed, Inc., today announced the presentation of data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor. Data from the Phase 1 studies with ENMD-2076 in patients with multiple myeloma and relapsed or refractory leukemia were presented by EntreMed investigators during poster sessions at the 2010 American Society of Hematology Annual Meeting being held December 4-7 in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Northstar Sleep Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124315700 PECOS PAC ID: 7315104064 Enrollment ID: O20120207000849 |
News Archive
One of the doctors who will NOT be standing behind the President today is one of his most vocal opponents. But he would have been there if the White House had its way.
The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
EntreMed, Inc., today announced the presentation of data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor. Data from the Phase 1 studies with ENMD-2076 in patients with multiple myeloma and relapsed or refractory leukemia were presented by EntreMed investigators during poster sessions at the 2010 American Society of Hematology Annual Meeting being held December 4-7 in Orlando, Florida.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joan Mk Fox, MD 920 E 28th St # St5, Suite 700, Minneapolis, MN 55407-1139 Ph: (612) 863-9062 | Joan Mk Fox, MD 920 E 28th St # St5, Suite 700, Minneapolis, MN 55407-1139 Ph: (612) 863-9062 |
News Archive
One of the doctors who will NOT be standing behind the President today is one of his most vocal opponents. But he would have been there if the White House had its way.
The Gene Therapy Review was first launched in 2008 as an online source of information on all aspects of gene therapy with sections comprising information on gene therapy research, news, disease targets, patient resources and companies offering services to the gene therapy community. It then further featured a clinical trials database detailing all gene therapy clinical procedures completed to date.
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
EntreMed, Inc., today announced the presentation of data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor. Data from the Phase 1 studies with ENMD-2076 in patients with multiple myeloma and relapsed or refractory leukemia were presented by EntreMed investigators during poster sessions at the 2010 American Society of Hematology Annual Meeting being held December 4-7 in Orlando, Florida.
› Verified 9 days ago
Pascal Frino, M.D Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |